Protalix BioTherapeutics
PLX
#8601
Rank
C$0.35 B
Marketcap
C$4.16
Share price
-5.23%
Change (1 day)
68.53%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): C$0.43

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is C$0.44. In 2025 the company made an earnings per share (EPS) of C-$0.11 a decrease over its 2024 EPS that were of C$0.05736.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$0.43-477.03%
2025C-$0.11-300%
2024C$0.05736-66.67%
2023C$0.17-138.71%
2022C-$0.44-50%
2021C-$0.89181.82%
2020C-$0.32-82.11%
2019C-$1.76-31.67%
2018C-$2.58-72.31%
2017C-$9.32124.14%
2016C-$4.16-147.54%
2015C$8.75-290.63%
2014C-$4.596.67%
2013C-$4.30130.77%
2012C-$1.86-69.77%
2011C-$6.1719.44%
2010C-$5.16-12.2%
2009C-$5.8836.67%
2008C-$4.30-37.5%
2007C-$6.8850%
2006C-$4.593.23%
2005C-$4.45138.46%
2004C-$1.86-74%
2003C-$7.17-0%
2002C-$7.17-50%
2001C-$14.34233.33%
2000C-$4.30-84.21%
1999C-$27.25-24%
1998C-$35.85-600%
1997C$7.17-16.67%
1996C$8.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.02 129.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$10.00 2,148.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.16-135.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.65 45.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel